Biomarkers for Prediction and Diagnosis of Necrotizing Enterocolitis

Clinics in Perinatology

Volumn 40, Issue 1, 2013, Pages 149-159

  Ng, Pak C ^a   Chan, Kathy Y Y ^a   Poon, Terence C W ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Biomarkers; Diagnosis; Infants; Necrotizing enterocolitis; Preterm

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CD64 ANTIGEN; FATTY ACID BINDING PROTEIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MICRORNA; PROCALCITONIN; RANTES; SERUM AMYLOID A; UNTRANSLATED RNA;

BACTERIAL COLONIZATION; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; EARLY DIAGNOSIS; FECES ANALYSIS; GENE; GENETIC MARKER; HUMAN; IL 4 RECEPTOR ALPHA GENE; IL 8 GENE; INTESTINE FLORA; MBL2 GENE; METAGENOMICS; MICROARRAY ANALYSIS; NECROTIZING ENTEROCOLITIS; NEWBORN CARE; NEWBORN SEPSIS; NFKB1 GENE; NONHUMAN; OXIDATIVE STRESS; PREDICTION; PREMATURITY; PRIORITY JOURNAL; PROTEOMICS; REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY; VERY LOW BIRTH WEIGHT;

EID: 84873715860     PISSN: 00955108     EISSN: 15579840     Source Type: Journal    
DOI: 10.1016/j.clp.2012.12.005     Document Type: Review

References (57)

1. Neu J., Walker W.A. Necrotizing enterocolitis. N Engl J Med 2011, 364(3):255-264.
2. Lin P.W., Stoll B.J. Necrotising enterocolitis. Lancet 2006, 368(10):1271-1283.
3. Lam H.S., Wong S.P., Cheung H.M., et al. Early diagnosis of intra-abdominal inflammation and sepsis by neutrophil CD64 expression in newborns. Neonatology 2011, 99(2):118-124.
4. Hintz S.R., Kendrick D.E., Stoll B.J., et al. Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis. Pediatrics 2005, 115(3):696-703.
5. Salhab W.A., Perlman J.M., Silver L., et al. Necrotizing enterocolitis and neurodevelopmental outcome in extremely low birth weight infants <1000 g. J Perinatol 2004, 24(9):534-540.
6. Ng P.C., Ang I.L., Chiu R.W., et al. Host-response biomarkers for diagnosis of late-onset septicemia and necrotizing enterocolitis in preterm infants. J Clin Invest 2010, 120(8):2989-3000.
7. Kosloske A.M., Musemeche C.A., Ball W.S., et al. Necrotizing enterocolitis: value of radiographic findings to predict outcome. Am J Roentgenol 1988, 151(4):771-774.
8. Ng P.C., Cheng S.H., Chui K.M., et al. Diagnosis of late onset neonatal sepsis with cytokines, adhesion molecule, and C-reactive protein in preterm very low birth weight infants. Arch Dis Child Fetal Neonatal Ed 1997, 77(3):221-227.
9. Pourcyrous M., Korones S.B., Yang W., et al. C-reactive protein in the diagnosis, management and prognosis of neonatal necrotizing enterocolitis. Pediatrics 2005, 116(5):1064-1069.
10. Centinkaya M., Ozkan H., Koksal N., et al. Comparison of the efficacy of serum amyloid A, C-reactive protein, and procalcitonin in the diagnosis and follow-up of necrotizing enterocolitis in premature infants. J Pediatr Surg 2011, 46(8):1482-1489.
11. Ng P.C., Li K., Chui K.M., et al. IP-10 is an early diagnostic marker for identification of late-onset bacterial infection in preterm infants. Pediatr Res 2007, 61(1):93-98.
12. Ng P.C., Li K., Wong R.P., et al. Neutrophil CD64 expression: a sensitive diagnostic marker for late-onset nosocomial infection in very low birth weight infants. Pediatr Res 2002, 51(3):296-303.
13. Bhandari V., Wang C., Rinder C., et al. Hematologic profile of sepsis in neonates: neutrophil CD64 as a diagnostic marker. Pediatrics 2008, 121(1):129-134.
14. Turunen R., Andersson S., Nupponen I., et al. Increased CD11b-density on circulating phagocytes as an early sign of late-onset sepsis in extremely low-birth-weight infants. Pediatr Res 2005, 57(2):270-275.
15. Ng P.C., Lam H.S. Biomarkers in neonatology: the next generation of test. Neonatology 2012, 102(2):145-151.
16. Kirsten G.F., van Zyl N., Smith M., et al. Necrotizing enterocolitis in infants born to women with severe early preeclampsia and absent end-diastolic umbilical artery Doppler flow velocity waveforms. Am J Perinatol 1999, 16(6):309-314.
17. Kamoji V.M., Dorling J.S., Manktelow B., et al. Antenatal umbilical Doppler abnormalities: an independent risk factor for early onset neonatal necrotizing enterocolitis in premature infants. Acta Paediatr 2008, 97(3):327-331.
18. Young C., Sharma R., Handfield M., et al. Biomarkers for infants at risk for necrotizing enterocolitis: clues to prevention?. Pediatr Res 2009, 65(5):91R-97R.
19. Blau J., Calo J.M., Dozor D., et al. Transfusion-related acute gut injury: necrotizing enterocolitis in very low birth weight neonates after packed red blood cell transfusion. J Pediatr 2011, 158(3):403-409.
20. Singh R., Visintainer P.F., Frantz I.D., et al. Association of necrotizing enterocolitis with anemia and packed red blood cell transfusions in preterm infants. J Perinatol 2011, 31(1):176-182.
21. Prencipe G., Azzari C., Moriondo M., et al. Association between mannose-binding lectin gene polymorphisms and necrotizing enterocolitis in preterm infants. J Pediatr Gastroenterol Nutr 2012, 55(2):160-165.
22. IP W.K., Takahashi K., Ezekowitz R.A., et al. Mannose-binding lectin and innate immunity. Immunol Rev 2009, 230(1):9-21.
23. Sampath V., Le M., Lane L., et al. The NFKB1 (g.-24519delATTG) variant is associated with necrotizing enterocolitis (NEC) in premature infants. J Surg Res 2011, 169(1):e51-e57.
24. Heninger E., Treszl A., Kocsis I., et al. Genetic varients of the interleukin-18 promoter region (-607) influence the course of necrotizing enterocolitis in very low birth weight neonates. Eur J Pediatr 2002, 161(7):410-411.
25. Treszl A., Heninger A., Kalman A., et al. Low prevalence of IL-4 receptor alpha-chain gene G variant in very-low-birth-weight infants with necrotizing enterocolitis. J Pediatr Surg 2003, 38(9):1374-1378.
26. Moonen R.M., Paulussen A.D., Souren N.Y., et al. Carbamoyl phosphate synthetase polymorphisms as a risk factor for necrotizing enterocolitis. Pediatr Res 2007, 62(2):188-190.
27. Szebeni B., Szekeres R., Rusai K., et al. Genetic polymorphisms of CD14, toll-like receptor 4, and caspase-recruitment domain 15 are not associated with necrotizing enterocolitis in very low birth weight infants. J Pediatr Gastroenterol Nutr 2006, 42(1):27-31.
28. Henderson G., Craig S., Baier R.J., et al. Cytokine gene polymorphisms in preterm infants with necrotising enterocolitis: genetic association study. Arch Dis Child Fetal Neonatal Ed 2009, 94(2):F124-F128.
29. Harding D. Impact of common genetic variation on neonatal disease and outcome. Arch Dis Child Fetal Neonatal Ed 2007, 92(5):F408-F413.
30. Perrone S., Tataranno M.L., Negro S., et al. May oxidative stress biomarkers in cord blood predict the occurrence of necrotizing enterocolitis in preterm infants?. J Matern Fetal Neonatal Med 2012, 25(Suppl 1):128-131.
31. Mai V., Young C.M., Ukhanova M., et al. Fecal microbiota in premature infants prior to necrotizing enterocolitis. PLoS One 2011, 6:e20647.
32. Wang Y., Hoenig J.D., Malin K.J., et al. 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis. ISME J 2009, 3(8):944-954.
33. Smith B., Bode S., Petersen B.L., et al. Community analysis of bacteria colonizing intestinal tissue of neonates with necrotizing enterocolitis. BMC Microbiol 2011, 11(4):73.
34. Morowitz M.J., Denef V.J., Costello E.K., et al. Strain-resolved community genomic analysis of gut microbial colonization in a premature infants. Proc Natl Acad Sci U S A 2011, 108(3):1128-1133.
35. Ng P.C., Li K., Leung T.F., et al. Early prediction of sepsis-induced disseminated intravascular coagulation with interleukin-10, interleukin-6, and RANTES in preterm infants. Clin Chem 2006, 52(6):1181-1189.
36. Tayman C., Tonbul A., Kahveci H., et al. C5a, a complement activation product, is a useful marker in predicting the severity of necrotizing enterocolitis. Tohoku J Exp Med 2011, 224(2):143-150.
37. Ng P.C., Lam H.S. Biomarkers for late-onset neonatal sepsis: cytokines and beyond. Clin Perinatol 2010, 37(3):599-610.
38. Ng P.C., Li K., Wong R.P., et al. Proinflammatory and anti-inflammatory cytokine responses in preterm infants with systemic infections. Arch Dis Child Fetal Neonatal Ed 2003, 88(3):209-213.
39. Chan K.Y., Leung F.W., Lam H.S., et al. Immunoregulatory protein profiles of necrotizing enterocolitis versus spontaneous intestinal perforation in preterm infants. PLoS One 2012, 7(5):e36977.
40. Turner D., Hammerman C., Rudensky B., et al. Low levels of procalcitonin during episodes of necrotizing enterocolitis. Dig Dis Sci 2007, 52(11):2972-2976.
41. Khoo A.K., Hall N.J., Alexander N., et al. Plasma soluble e-selectin in necrotizing enterocolitis. Eur J Pediatr Surg 2008, 18(6):419-422.
42. Kultursay N., Kantar M., Akisu M., et al. Platelet-activating factor concentrations in healthy and septic neonates. Eur J Pediatr 1999, 158(9):740-741.
43. Caplan M.S., Sun X.M., Hseuh W., et al. Role of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis. J Pediatr 1990, 116(6):960-964.
44. Aydemir C., Dilli D., Oguz S.S., et al. Serum intestinal fatty acid binding protein level for early diagnosis and prediction of severity of necrotizing enterocolitis. Early Hum Dev 2011, 87(10):659-661.
45. Edelson M.B., Sonnino R.E., Bagwell C.E., et al. Plasma intestinal fatty acid binding protein in neonates with necrotizing enterocolitis: a pilot study. J Pediatr Surg 1999, 34(10):1453-1457.
46. Mannoia K., Boskovic D.S., Slater L., et al. Necrotizing enterocolitis is associated with neonatal intestinal injury. J Pediatr Surg 2011, 46(1):81-85.
47. Thuijls G., Derikx J.P., van Wijck K., et al. Non-invasive markers for early diagnosis and determination of the severity of necrotizing enterocolitis. Ann Surg 2010, 251(6):1174-1180.
48. Campeotto F., Baldassarre M., Butel M.J., et al. Fecal calprotectin: cutoff values for identifying intestinal distress in preterm infants. J Pediatr Gastroenterol Nutr 2009, 48(4):507-510.
49. Josefsson S., Bunn S.K., Domellof M. Fecal calprotectin in very low birth weight infants. J Pediatr Gastroenterol Nutr 2007, 44(4):407-413.
50. Gollin G., Marks W.H. Elevation of circulating intestinal fatty acid binding protein in a luminal contents - Initiated model of NEC. J Pediatr Surg 1993, 28(3):367-371.
51. Derikx J.P., Poeze M., van Bijnen A.A., et al. Evidence for intestinal and liver epithelial cell injury in the early phase of sepsis. Shock 2007, 28(5):544-548.
52. van de Poll M.C., Derikx J.P., Buurman W.A., et al. Liver manipulation causes hepatocyte injury and precedes system inflammation in patients undergoing liver resection. World J Surg 2007, 31(10):2033-2038.
53. Vasilescu C., Rossi S., Shimizu M., et al. MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis. PLoS One 2009, 4:e7405.
54. Wu F., Zhang S., Dassopoulos T., et al. Identification of microRNAs associated with ileal and colonic Crohn's disease. Inflamm Bowel Dis 2010, 16(10):1729-1738.
55. Voelkerding K.V., Dames S.A., Durtschi J.D. Next-generation sequencing: from basic research to diagnostics. Clin Chem 2009, 54(4):641-658.
56. Chiu R.W., Cantor C.R., Lo Y.M. Non-invasive prenatal diagnosis by single molecule counting technologies. Trends Genet 2009, 25(7):324-331.
57. Chiu R.W., Akolekar R., Zheng Y.W., et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ 2011, 342:c7401.